Peer Review: Anil Singhal assumes leadership of Adicet Bio; Adaptive Biotech woos Genentech vet as CMO
→ More than a year after Aya Jakobovits abruptly vacated the CEO office, Adicet Bio has found her permanent successor just ahead of its first IND. Anil Singhal takes over from Donald Santel, the executive chairman who’s been filling the role. An AbbVie vet, Singhal joins the immunotherapy company with some fresh biotech experience as executive-in-residence at Canaan Partners and CSO of OncoResponse.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.